(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

S

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

S

ST13

US500000087025435

Class

35

Filing

87025435

Registration

5064393

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

07/28/2026

Trademark type

Combined

Nice classes

35

Filing date

05/04/2016

Registration date

10/18/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2026

Last transaction

07/28/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/01/2015

First use in commerce

08/01/2015

Drawing code

3

Owner type

16

Owner location

GREENWICH, CT, US

Examiner

HESIK, APRIL ANNE

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a hexagon with a single line border as a carrier for a stylized letter "S", which letter "S" is formed by two intersecting incomplete squares that each resemble a two-dimensional molecular model, with the corner of each square punctuated by a circular node.

Holders and representatives

Holders

ASSEMBLED INTELLIGENCE LLC
Stratevi, LLC

Representatives

Anuj Desai Arnall Golden Gregory LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Brand development and evaluation services in the field of pharmaceuticalbiotechnology and medical devices; Marketing consultation in the field of pharmaceuticalbiotechnology and medical devices; Providing economic consultation in field of pharmaceuticalbiotechnologymedical devices and health outcomes research

Publications

History of USPTO decisions and trademark events.

27 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/09/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/09/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/09/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/09/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

05/08/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/25/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/08/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/08/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/08/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/08/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/08/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/05/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/18/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/18/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/18/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/12/2022

E815

TEAS SECTION 8 & 15 RECEIVED

10/28/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/18/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

10/18/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/02/2016

PUBO

PUBLISHED FOR OPPOSITION

08/02/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/13/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/23/2016

DOCK

ASSIGNED TO EXAMINER

06/22/2016

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/11/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/10/2016

NWAP

NEW APPLICATION ENTERED

05/07/2016

Continuous trademark protection

Get notified about every new filing that threatens S or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.